MYRIAD GENETICS INC 4
4 · MYRIAD GENETICS INC · Filed Sep 16, 2016
Insider Transaction Report
Form 4
Tobin Bernard
President Crescendo BioScience
Transactions
- Award
Common Stock
2016-09-14+49,608→ 86,220 total - Award
Common Stock
2016-09-14+40,000→ 126,220 total
Footnotes (2)
- [F1]Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019.
- [F2]Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.